[EN] BROMODOMAIN INHIBITOR<br/>[FR] INHIBITEUR DE BROMODOMAINE
申请人:CELGENE QUANTICEL RES INC
公开号:WO2016168682A2
公开(公告)日:2016-10-20
The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of cancer and neoplastic disease.